Methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate
97%
- Product Code: 118846
CAS:
143878-29-9
| Molecular Weight: | 269.68 g./mol | Molecular Formula: | C₁₂H₁₂ClNO₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22381061 | |
| Melting Point: | Boiling Point: | 492.0±45.0°C at 760 mmHg | |
| Density: | 1.401g/cm3 | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules. Its structural features make it suitable for developing compounds with potential therapeutic applications, particularly in the design of drugs targeting neurological disorders or pain management. The presence of functional groups like the acetamido and carboxylate moieties allows for further chemical modifications, enabling the creation of derivatives with enhanced pharmacological properties. Researchers often explore its utility in creating novel drug candidates, focusing on optimizing efficacy and reducing side effects.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | Ft6,011.95 |
+
-
|
| 0.250 | 10-20 days | Ft9,890.63 |
+
-
|
| 1.000 | 10-20 days | Ft29,962.79 |
+
-
|
Methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules. Its structural features make it suitable for developing compounds with potential therapeutic applications, particularly in the design of drugs targeting neurological disorders or pain management. The presence of functional groups like the acetamido and carboxylate moieties allows for further chemical modifications, enabling the creation of derivatives with enhanced pharmacological properties. Researchers often explore its utility in creating novel drug candidates, focusing on optimizing efficacy and reducing side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :